The content of acetylcholine (ACh) in nerve terminals or the dorsal hippocampus was examined after intraventricular, intraseptal, or intrahippocampal administration of a variety of endorphin/ corticotropin neuropeptides. ,&Lipotropin, a-endorphin, y-endorphin, a-melanotropin, /%melanotro-pin, adrenocorticotropin-1-39 (ACTHI-&, and ACTH4-lo (1,3,10, or 30 pg each) did not affect levels of ACh in the hippocampus 30 min after injection into the lateral ventricle. P-Endorphin, administered intraventricularly (1, 3, 10, or 30 pg) or intraseptally (1 pg), increased levels of ACh, while ACTHI+ injected similarly, decreased levels of the neurotransmitter. ACh concentrations remained unchanged after direct application of P-endorphin or ACTHI-(1,3,10, or 30 pg each) into Ammon's horn.
tivity of this group of neurons. These include intrinsic y-aminobutyric-acid-containing neurons (McLennan and Miller, 1974; DeFrance et al., 1975) , dopamine afferents emanating from the ventral tegmentum (Assaf and Miller, 1977; Moore, 1978) , noradrenergic neurons from the locus coeruleus and caudal brainstem (Moore, 1978) , as well as substance P afferents arising from the medial basal hypothalamus (Cuello and Kanazawa, 1978; Malthe-Sgrenssen et al., 1978) .
Endorphin and corticotropin peptidergic systems also affect the activity of this group of limbic forebrain neurons. /?-Endorphin, administered into the lateral ventricle, increases hippocampal acetylcholine (ACh) levels without changing the concentrations of this neurotransmitter in the cortex or striatum (Botticelli and Wurtman, 1979) ; given intraseptally, it causes a naltrexone-reversible decrease in the turnover of hippocampal ACh (Moroni et al., 1978) . The opioid neuropeptide and adrenocorticotropin-l-14 (ACTHI-z4) increase and decrease, respectively, hippocampal ACh levels after intraventricular
The Journal of Neuroscience Endorphin/Corticotropin Neuropeptides and Septohippocampal ACh 1317 or intraseptal injection (Botticelli and Wurtman, 1981) . to bregma and 3 mm ventral to the dural surface) 3 d Co-administration of endorphin and corticotropin blocks before experimentation. Cannulae were kept in position the effects of both on ACh concentrations in the hippo-with dental cement. All intraventricular injections (10 campal formation (Botticelli and Wurtman, 1980, 1981) . fi over a 5-min period) were made, under visual guidance, When the neuropeptides are applied directly to the hip-using a microsyringe (Hamilton Co., Reno, NV) lowered pocampus, ACh levels remain unchanged (Botticelli and through the polyethylene sleeve 3 mm ventral to the Wurtman, 1981). These observations suggest that the dural surface. Microadministration into the lateral venneuropeptides may act at the level of cholinergic cell tricle was verified by visualizing the distribution of methbodies in the septal region to modulate the activity of ylene blue throughout the cerebroventricular system. septal cholinergic afferents terminating in Ammon's For intraseptal injections, guide cannulae (28 gauge, horn.
Plastic Products Co., Roanoke, VA) were implanted sterWe now describe the ability of a variety of endorphin/ eotaxically into the septum (coordinates: AP 8.6, ML 0.0, corticotropin neuropeptides, microadministered at vary-DV 0.0, 5.0 mm ventral to the dural surface) 5 d before ing doses into the lateral ventricle, the septal region, or study. All intraseptal injections were made using a mithe hippocampus, to affect ACh levels in the hippocam-crosyringe in a final volume of 1.0 ~1 over a lo-min period. pal formation. Parallel studies were conducted in which Injection into the septum was verified by examining a 1:3 the neuropeptides were injected after acute unilateral series of 40-pm frozen frontal cryostat sections stained transection of a major afferent cholinergic channel to the with thionin or cresyl echt violet and by schematic rehippocampus (i.e., the fimbria/superior fornix). In addi-construction drawings using the stereotaxic atlases of tion, the effects of naloxone administration on peptide- Konig and Klippel (1963) and Jacobowitz and Palkovits induced changes in hippocampal ACh levels are de-(1974) . For intrahippocampal injections, cannulae were scribed.
placed into the dorsal hippocampus (coordinates: AP 4.0, Materials and Methods ML 2.0, DV 2.0) 3 d before experimentation. Peptides were administered into the hippocampus using a microAnimals. Male Sprague-Dawley rats (Charles River syringe in a final volume of 1.0 ~1 over a 5-min period. Breeding Laboratories, Wilmington, MA), each weighing Histologic verification was made as described above. 150 to 200 gm, were housed in groups of two or three in Drug injections. Naloxone hydrochloride was dissolved suspended stainless steel wire cages at an ambient tem-in deionized distilled water and diluted to a concentration perature of 23 to 24'C for 5 to 7 d before experimentation. The animals had free access to food (Purina Rat Chow, that allowed the studied dose (1.0 mg/kg, s.c.) to be Ralston-Purina Co., St. Louis, MO) and water and were injected in a final volume of 0.1 ml/100 gm of body exposed to light (Vita-Lite, 300 pW/cm2, Duro-Test weight. When naloxone was injected into the lateral ventricle, a dose of 100 pg was used. The doses used refer Corp., North Bergen, NJ) daily between 7 AM and 7 PM. to the drug salts.
Chemicals. P-Endorphin (synthesized by Dr. C. H. Li, Hormone Research Laboratory, University of California Transection procedure. To separate the hippocampus from its cholinergic dorsal efferents, rats were anestheMedical Center, San Francisco, CA) was provided by the Psychopharmacology Research Branch, National Institized with methohexital sodium (50 mg/kg, 0.1 ml/100 gm of body weight) and then stabilized in a small animal tute of Mental Health, Bethesda, MD. P-Lipotropin (p-stereotaxic frame. A scalp wound was made midline and LPH) and P-melanotropin (/3-MSH) were gifts of Dr. C. H. Li. ACTH1-39, ACTHI+ ACTHdelo, and cY-melanotrothe skin was reflected laterally. The fimbria/superior pin ((u-MSH) were supplied by Organon Pharmaceuticals, fornix was cut unilaterally using a No. 11 scalpel blade Oss, The Netherlands. a-Endorphin and y-endorphin inserted vertically through a skull slot at a point 3.0 mm lateral to bregma to a point 1.0 mm lateral to lambda. were purchased from Peninsula Laboratories, San Carlos, The depth of the cut was 4.0 mm from the rostral to CA. Naloxone hydrochloride was a gift of Endo Laboratories, Garden City, NY. Acetylcholinesterase (acetylcaudal aspects (Storm-Mathisen and Guldberg, 1974) . Vol. 2, No. 9, Sept. 1982 rpm for 20 min at 2°C in a Beckman TJ-6 centrifuge (Beckman Instruments, Spinco Division, Palo Alto, CA). The aqueous supernatant solutions were extracted individually with 300 ~1 of tetraphenylboron/3-heptanone (5 mg/ml, Aldrich), mixed on a Vortex mixer, and centrifuged again at 2000 rpm for 10 min at 2°C. The resulting organic phase (200 ~1) was back-extracted with 300 ~1 of 0.4 N HCl. After mixing and recentrifugation, the organic phase was aspirated and 100~~1 aliquots of the acid phase were transferred to 6 x 50 mm culture tubes (Kimble, Toledo, OH) and centrifuged to dryness using a Savant Speed-Vat Concentrator (Savant Instruments, Hicksville, NY).
After the lyophilisate was reconstituted in deionized distilled water, endogenous Ch was phosphorylated to unlabeled PCh in the presence of 0.1 M ATP and choline kinase. ACh then was hydrolyzed by acetylcholinesterase and the resulting Ch was phosphorylated using [Y-~'P] ATP as the substrate.
After incubation at 30°C for 10 min, this reaction was quenched by the addition of 200 ,ul of ice cold deionized distilled water. Umeacted [y-""PI ATP was removed by passing the mixture over 0.5 x 5.0 cm Dowex anion exchange columns 200 to 400 mesh, formate form; Bio-Rad Laboratories, Richmond, CA). [Y-~'P]ATP was eluted with 2.0 ml of 75 mM ammonium formate, collected into polyethylene scintillation vials (Kimble) containing 15 ml of Scintiverse (Fisher Scientific Co., Fair Lawn, NJ), and counted in a Beckman LS-7500 liquid scintillation spectrometer (Beckman Instruments, Irvine, CA). ACh content, expressed as nanomoles per gm, was determined by linear regression analysis and then by dividing the total nanomoles of ACh per sample by the respective tissue weights.
Statistical analyses.
The significance of treatmentinduced differences in hippocampal ACh was determined by an analysis of variance (Wang 2200 series software, Wang Laboratories, Lowell, MA) followed by aposteriori multiple comparisons using Scheffe's method (Winer, 1971) .
Results
Effects of intraventricular, intraseptal, or intrahippocampal neuropeptides on hippocampal ACh. Levels of hippocampal ACh remained unchanged after intraventricular administration of fi-LPH, a-endorphin, y-endorphin, ACTH1-s9, ACTHdelo, a-MSH, or ,&MSH (1, 3, 10, or 30 pg each). Over the same dose range, ,&-endorphin or ACTH1-24 increased or decreased, respectively, hippocampal ACh levels (Table I ). Naloxone hydrochloride (1 mg/kg, s.c.), which alone had no effect of ACh concentrations, antagonized fully endorphinor corticotropininduced changes in hippocampal ACh (Table II) .
Microinjection of /?-endorphin or ACTHI-24 (1.0 pg each) into the septal region affected levels of hippocampal ACh as they did after intraventricular peptide injection but to a greater extent. /3-Endorphin increased ACh content, while ACTHlmZ4 decreased levels of the neurotransmitter (Table III) . Intraventricular naloxone administration (100 pg), which alone failed to affect hippocampal ACh, blocked fully peptide-induced changes in ACh levels (Table III) .
Administration of P-endorphin or ACTHI-24 (1, 3, 10, or 30 pg each) directly into the hippocampal formation did not change ACh levels in Ammon's horn (Table IV) .
None of the treatments altered hippocampal choline levels (data not shown).
Effects of unilateral fimbrial transection on peptideinduced changes in hippocampal ACh. Unilateral transection of the fimbria/superior fornix resulted in a timerelated decrease in hippocampal ACh levels. Concentrations of the neurotransmitter did not change 1 hr after transection; however, hippocampal ACh levels decreased to 72 and 26% of control values 1 d and 1 week, respectively, after deafferentation.
ACh levels in the contralateral intact hippocampus remained unaffected at all times tested (Table V) . Fimbrial transection, performed 90 min before neuropeptide administration, blocked fully endorphin-or corticotropin-induced changes in hippocampal ACh after the neuropeptides were injected into either the lateral ventricle (10 pg) or septal region (1.0 pg) (Table VI) .
Discussion
These data show that ,&endorphin and ACTH1-24, injected into the lateral ventricle, produce opposite and dose-dependent changes in ACh levels within terminals of septohippocampal neurons: /?-endorphin increases hip- pocampal ACh, while ACTHI-24 decreases levels of the neurotransmitter. When peptides are injected into the septum, hippocampal ACh changes similarly but to a greater extent. Direct application of either substance into Ammon's horn is, regardless of dose, without effect on hippocampal ACh. Fimbrial transection fully blocks both endorphin-and corticotropin-induced changes in hippocampal ACh after the neuropeptides are injected into either the lateral ventricle or the septal region. Naloxone, which, after subcutaneous or intraventricular injection, fails to change hippocampal ACh levels, antagonizes the change produced by both endorphin and corticotropin. These observations suggest that P-endorphin and ACTH1-z4 may act at receptor sites on membranes of cell bodies in the septal region to modulate the activity of septal cholinergic afferents terminating in Ammon's horn.
The medial septal nucleus and the nucleus of the ap < 0.001 differs from vehicle-treated animals. bp < 0.005 differs from vehicle-treated animals. 'p < 0.001 differs from peptide-treated animals. dp < 0.005 differs from peptide-treated animals. diagonal band contain the cells of origin of septohippocampal cholinergic neurons. Fibers project by way of the fimbria/superior fornix and enter the hippocampal formation at the level of the stratum oriens to synapse on basal dendrites of pyramidal cells in Ammon's horn, in the hilar portion of the dentate gyrus, the subiculum and parasubiculum, and the entorhinal cortex (Swanson, 1978) . The septal region is also the recipient of the major hypothalamic efferents emanating from such diencephalic regions as the arcuate nucleus, an area within which opiomelenocortin perikarya are found in abundance (Watson et al., 1978a, b; Botticelli, 1980) . In addition, hippocampal efferent channels synapse in the lateral septal area which, in turn, adjoins the medial septal nuclei (Swanson, 1978) . The septohippocampal cholinergic neurons receive axodendritic and axosomatic synapses in the septal region and axoaxonic synapses in the hippocampus. Moroni et al. (1978) observed that intraseptally administered /3-endorphin produces a naltrexone-reversible decrease in the turnover of hippocampal ACh without changing levels of the neurotransmitter. Corticotropin and (u-MSH were reported by Wood et al. (1979) to increase ACh turnover in Ammon's horn (without altering hippocampal ACh) even after transection of the major afferents emanating from such areas as the BotticeIIi and Wurtman Vol. 2, No. 9, Sept. 1982 Simantov, 1979; Botticelli and Wurtman, 1980, 1981) ;
"p < 0.01 differs from vehicle-treated animals.
perhaps some of the neurons that release them partici-*p < 0.001 differs from intact, contralateral hippocampus.
pate reciprocally in common multisynaptic systems.
'p < 0.005 differs from vehicle-treated animals.
Strategically interposed, the septum appears to govern dp < 0.005 differs from intact, contralateral hippocampus.
neuronal associations among prominent structures of the 'p < 0.05 differs from vehicle-treated animals.
'p < 0.05 differs from intact, contralateral hippocampus.
mammalian central nervous system. The functional set "p < 0.005 differs from vehicle-treated animals.
of the septohippocampal system thus may be viewed as "p < 0.005 differs from intact, contralateral hippocampus.
processing a wide variety of sensory, visceral, and associative information. By acting at the level of the septal cingulum, entorhinal cortex, and fimbria/superior fornix. region, endorphin/corticotropin neuropeptides may regThese latter findings were interpreted as suggesting a ulate the activity of a prominent set of choline+ neudirect action of the neuropeptides on receptors in the rons within the limbic domain and participate rather hippocampus. Our observations that intraventricular or broadly in the information-processing mechanisms and intraseptal, but not intrahippocampal, /3-endorphin and synaptic organization of the mammalian basal forebrain.
